Heterogeneous Flare in Prostate-specific Membrane Antigen Positron Emission Tomography Tracer Uptake with Initiation of Androgen Pathway Blockade in Metastatic Prostate Cancer-Reference-Cited by-同舟云学术

Heterogeneous Flare in Prostate-specific Membrane Antigen Positron Emission Tomography Tracer Uptake with Initiation of Androgen Pathway Blockade in Metastatic Prostate Cancer

Published:2018-05 Issue:1 Volume:1 Page:78-82
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Aggarwal Rahul,Wei Xiao,Kim Won,Small Eric J.,Ryan Charles J.,Carroll Peter,Cooperberg Matthew,Evans Michael J.,Hope Thomas

Publisher

Elsevier BV

Subject

Urology,Radiology Nuclear Medicine and imaging,Oncology,Surgery

Reference10 articles.

1. Comparison of prostate-specific membrane antigen-based 18F-DCFBC PET/CT to conventional imaging modalities for detection of hormone-naïve and castration-resistant metastatic prostate cancer;Rowe;J Nucl Med,2016

2. Comparison of bone scintigraphy and 68Ga-PSMA PET for skeletal staging in prostate cancer;Pyka;Eur J Nucl Med Mol Imaging,2016

3. Overall survival and response pattern of castration-resistant metastatic prostate cancer to multiple cycles of radioligand therapy using [177Lu]-PSMA-617;Ahmadzadehfar;Eur J Nucl Med Mol Imaging,2017

4. 177Lu-labeled prostate-specific membrane antigen radioligand therapy of metastatic castration-resistant prostate cancer: safety and efficacy;Baum;J Nucl Med,2016

5. 177Lu-PSMA-617 radioligand therapy and outcome in patients with metastasized castration-resistant prostate cancer;Bräuer;Eur J Nucl Med Mol Imaging,2017

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From Oncogenesis to Theranostics: The Transformative Role of PSMA in Prostate Cancer;Cancers;2024-08-31

2. Correlation of [68Ga]Ga-PSMA PET/CT response and PSA decline in first-line enzalutamide for metastatic castration-resistant prostate cancer patients;European Journal of Nuclear Medicine and Molecular Imaging;2024-08-29

3. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II—2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer;European Urology;2024-08

4. PSMA-Targeted Radiopharmaceuticals for Prostate Cancer Diagnosis and Therapy;The Cancer Journal;2024-05

5. Role of Ga68 Prostate-Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Prostate Cancer Imaging;Journal of Gastrointestinal and Abdominal Radiology;2024-05